Department of Oral Biology, Fourth Military Medical University, Xi'an, Shaanxi, China.
Tissue Eng Part C Methods. 2013 Jan;19(1):1-14. doi: 10.1089/ten.TEC.2012.0126. Epub 2012 Jul 17.
Autologous adipose transplantation is rapidly gaining popularity for the restoration of soft tissue defects and lipoatrophy as well as for aesthetic improvements (e.g., facial reconstruction and rejuvenation). However, the current technique is crude that suffers from serious demerits, particularly the long-term unpredictability of volume maintenance due to resorption of the grafted adipose tissue and limited adipogenesis. We hypothesized that the adjuvant use of patient-derived adipose stromal vascular fraction (SVF) and platelet-rich fibrin (PRF) may enhance the overall outcome of autologous fat grafting in plastic and reconstructive surgery. Autologous SVF, with a mean cell number of (4.8±3.79)×10⁷ cells/mL and a mean cell viability of 71.8%, and autologous PRF, with sustained release of multiple angiogenic growth factors, were created before surgical use. The following adipose tissue implants were injected subcutaneously into a rabbit ear's auricula according to the following study design: 2 mL adipose granules and 0.2 mL normal saline solution (AG+NS group), 2 mL adipose granules and 0.2 mL SVF (AG+SVF group), 2 mL adipose granules and 0.2 mL PRF (AG+PRF group), or 2 mL adipose granules combined with 0.1 mL SVF and 0.1 mL PRF (AG+SVF+PRF group). Histological examinations showed that the implanted adipose granules were well engrafted in the AG+SVF+PRF group, with a higher microvessel density 4 weeks postimplantation compared with the other three groups (p<0.01). Twenty-four weeks postimplantation, the resorption rates of implanted tissue in each group were 49.39%±9.47%, 27.25%±4.37%, 36.41%±8.47%, and 17.37%±6.22%, respectively, and were significantly different (p<0.01). The results demonstrated that the efficacy of adipose tissue implantation can be enhanced by using autologous PRF and SVF as therapeutic adjuvants, offering a clinically translatable strategy for soft tissue augmentation and reconstruction.
自体脂肪移植技术因其在软组织缺损和脂肪萎缩的修复以及美容改善(如面部重建和年轻化)方面的应用而迅速普及。然而,目前的技术还比较粗糙,存在严重的缺点,特别是由于移植脂肪组织的吸收,脂肪体积的长期维持不可预测,以及脂肪生成能力有限。我们假设辅助使用患者来源的脂肪基质血管成分(SVF)和富含血小板的纤维蛋白(PRF)可能会提高整形和重建手术中自体脂肪移植的整体效果。在手术前,制备自体 SVF,其平均细胞数为(4.8±3.79)×10⁷ 个细胞/mL,细胞活力为 71.8%;制备自体 PRF,其可持续释放多种血管生成生长因子。根据以下研究设计,将以下脂肪组织植入物皮下注射到兔耳的耳廓中:2 mL 脂肪颗粒和 0.2 mL 生理盐水(AG+NS 组)、2 mL 脂肪颗粒和 0.2 mL SVF(AG+SVF 组)、2 mL 脂肪颗粒和 0.2 mL PRF(AG+PRF 组),或 2 mL 脂肪颗粒与 0.1 mL SVF 和 0.1 mL PRF 联合(AG+SVF+PRF 组)。组织学检查显示,在 AG+SVF+PRF 组中,植入的脂肪颗粒被很好地移植,在植入后 4 周时的微血管密度高于其他三组(p<0.01)。植入后 24 周时,每组植入组织的吸收率分别为 49.39%±9.47%、27.25%±4.37%、36.41%±8.47%和 17.37%±6.22%,差异具有统计学意义(p<0.01)。结果表明,使用自体 PRF 和 SVF 作为治疗佐剂可以增强脂肪组织植入的效果,为软组织增强和重建提供了一种具有临床转化潜力的策略。